Dietary Wheat Amylase Trypsin Inhibitors Worsen Chronic Liver Disease in Pre-Clinical Models of Nash and Liver Fibrosis

被引：0
|
作者：
Khan, Muhammad Ashfag, Jr. [1 ,2 ]
Aslam, Misbah, Jr. [1 ,2 ,3 ]
Senkowski, Marcel Sacha, Jr. [1 ,2 ]
Qureshi, Muhammad Asif [1 ,2 ]
Weng, Shih Yen [1 ,2 ]
Kim, Yong Ook [1 ,2 ]
Schattenberg, Jorn M. [4 ]
Schuppan, Detlef [1 ,2 ,5 ]
机构：
[1] Univ Med Ctr Mainz, Inst Translat Immunol, Mainz, Germany
[2] Univ Med Ctr Mainz, Res Ctr Immunotherapy, Mainz, Germany
[3] Shaheed Benazir Bhutto Women Univ, Peshawar, KP, Pakistan
[4] Univ Med Ctr Mainz, Dept Med, Mainz, Germany
[5] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Boston, MA USA
来源：
HEPATOLOGY | 2018年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1811
引用
收藏
页码：1028A / 1029A
页数：2
相关论文
共 50 条
  • [21] Dietary Wheat Amylase Trypsin Inhibitors Impact Alzheimer's Disease Pathology in 5xFAD Model Mice
    Guilherme, Malena dos Santos
    Zevallos, Victor F.
    Pesi, Aline
    Stoye, Nicolai M.
    Vu Thu Thuy Nguyen
    Radyushkin, Konstantin
    Schwiertz, Andreas
    Schmitt, Ulrich
    Schuppan, Detlef
    Endres, Kristina
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (17) : 1 - 17
  • [22] Metabolic characterization of two different non-alcoholic fatty liver disease pre-clinical mouse models
    Gallego-Duran, Rocio
    Alvarez-Amor, Leticia
    Gil-Gomez, Antonio
    Rojas, Angela
    Munoz-Hernandez, Rocio
    Cardenas-Garcia, Antonio
    Maya-Miles, Douglas
    Montero-Vallejo, Rocio
    Gato, Sheila
    Sanchez-Torrijos, Yolanda
    Ampuero, Javier
    Martin, Francisco
    Romero-Gomez, Manuel
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2019, 111 (04) : 301 - 307
  • [23] A nutraceutical supplement rich in docosahexaenoic acid improves portal hypertension in a pre-clinical model of chronic liver disease
    Boyer-Diaz, Zoe
    Manicardi, Nicolo
    Aristu, Peio
    Abad, Laia
    Cordobilla, Begona
    Fernandez Iglesias, Anabel
    Ortega Ribera, Marti
    Carles Domingo, Joan
    Morata, Paloma
    Bosch, Jaime
    Gracia-Sancho, Jordi
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E435 - E436
  • [24] The Enhanced liver fibrosis score is associated with clinical outcomes and disease progression in patients with chronic liver disease
    Irvine, Katharine M.
    Wockner, Leesa F.
    Shanker, Mihir
    Fagan, Kevin J.
    Horsfall, Leigh U.
    Fletcher, Linda M.
    Ungerer, Jacobus P. J.
    Pretorius, Carel J.
    Miller, Gregory C.
    Clouston, Andrew D.
    Lampe, Guy
    Powell, Elizabeth E.
    LIVER INTERNATIONAL, 2016, 36 (03) : 370 - 377
  • [25] Establishment of Two Pre-Clinical Models of Childhood Liver Cancer as Tools for Drug Screening
    Royo, L.
    Aguilar, B.
    Carrillo-Reixach, J.
    Domingo-Sabat, M.
    Garrido, M.
    Guerra, L.
    Mozo, Y.
    Sabado, C.
    Guillen, G.
    Molino, J. A.
    Hernandez, F.
    Mateos, M. L.
    Plaza, D.
    Lopez-Santamaria, M.
    Sancho-Bru, P.
    Villanueva, A.
    Armengol, C.
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S355 - S355
  • [26] European liver fibrosis markers can predict clinical outcome in patients with chronic liver disease
    Parkes, J.
    Roderick, P.
    Harris, S.
    Gough, C.
    Wheatley, M.
    Alexander, G.
    Collier, J.
    Day, C.
    Lombard, M.
    Mutimer, D.
    Ramage, J.
    Dusheiko, G.
    Burt, A.
    Sampson, E.
    Rosenberg, W.
    GUT, 2008, 57 : A38 - A38
  • [27] Enhanced liver fibrosis test can predict clinical outcomes in patients with chronic liver disease
    Parkes, Julie
    Roderick, Paul
    Harris, Scott
    Day, Christopher
    Mutimer, David
    Collier, Jane
    Lombard, Martin
    Alexander, Graeme
    Ramage, John
    Dusheiko, Geoffrey
    Wheatley, Mark
    Gough, Carol
    Burt, Alastair
    Rosenberg, William
    GUT, 2010, 59 (09) : 1245 - 1251
  • [28] Enhanced liver fibrosis (ELF) score predicts clinical outcome in patients with chronic liver disease
    Parkes, J.
    Roderick, R.
    Harris, S.
    Gough, C.
    Wheatley, M.
    Alexander, G.
    Collier, J.
    Day, C.
    Lombard, M.
    Mutimer, D.
    Ramage, J.
    Dusheiko, G.
    Burt, A.
    Sampson, E. L.
    Rosenberg, W.
    CLINICAL CHEMISTRY, 2008, 54 (06) : A43 - A44
  • [29] A review of the clinical utility of the Enhanced Liver Fibrosis test in multiple aetiologies of chronic liver disease
    Patel, Preya Janubhai
    Connoley, Declan
    Rhodes, Freya
    Srivastava, Ankur
    Rosenberg, William
    ANNALS OF CLINICAL BIOCHEMISTRY, 2020, 57 (01) : 36 - 43
  • [30] KASL clinical practice guidelines for noninvasive tests to assess liver fibrosis in chronic liver disease
    Kim, Mi Na
    Han, Ji Won
    An, Jihyun
    Kim, Beom Kyung
    Jin, Young-Joo
    Kim, Seung-seob
    Lee, Minjong
    Lee, Han Ah
    Cho, Yuri
    Kim, Hee Yeon
    Shin, Yu Rim
    Yu, Jung Hwan
    Kim, Moon Young
    Choi, YoungRok
    Chon, Young Eun
    Cho, Eun Ju
    Lee, Eun Joo
    Kim, Sang Gyune
    Kim, Won
    Jun, Dae Won
    Kim, Seung Up
    CLINICAL AND MOLECULAR HEPATOLOGY, 2024, 30 : S5 - +
12345